| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.66B | 118.56B | 126.41B | 118.34B | 117.94B | 114.71B |
| Gross Profit | 27.31B | 29.30B | 25.70B | 18.88B | 23.82B | 27.86B |
| EBITDA | -29.69B | 13.92B | -28.17B | 1.69B | 7.78B | 9.73B |
| Net Income | -24.96B | 18.15B | -24.28B | -5.44B | 102.00M | 2.22B |
Balance Sheet | ||||||
| Total Assets | 169.40B | 150.70B | 149.43B | 186.33B | 190.00B | 191.40B |
| Cash, Cash Equivalents and Short-Term Investments | 35.16B | 47.70B | 13.50B | 11.21B | 10.55B | 18.98B |
| Total Debt | 92.14B | 57.27B | 93.54B | 93.95B | 93.82B | 94.34B |
| Total Liabilities | 131.81B | 96.66B | 133.19B | 148.08B | 146.08B | 148.32B |
| Stockholders Equity | 37.36B | 53.78B | 15.57B | 36.76B | 42.11B | 41.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.03B | 2.23B | 1.05B | -8.01B | -126.00M |
| Operating Cash Flow | 0.00 | 5.61B | 6.29B | 8.17B | 509.00M | 8.67B |
| Investing Cash Flow | 0.00 | 34.31B | -3.15B | -7.54B | -8.09B | -8.99B |
| Financing Cash Flow | 0.00 | -6.12B | -435.00M | -279.00M | -1.66B | -4.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥181.40B | 22.82 | ― | 2.84% | 4.10% | 5.25% | |
73 Outperform | ¥321.56B | 9.57 | 5.47% | 3.41% | 0.55% | 25.37% | |
73 Outperform | ¥402.09B | 9.42 | 9.59% | 3.91% | -2.06% | 46.42% | |
72 Outperform | ¥1.99T | 15.54 | 11.98% | 1.54% | 1.41% | 0.76% | |
65 Neutral | ¥141.17B | 10.40 | ― | 3.21% | -0.11% | 457.37% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | ¥90.75B | 3.64 | ― | ― | -6.21% | ― |